Joseph P. Talley
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Joseph P. Talley has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- Anne Elise Packard
Department of Physics and Astronomy, Brigham Young University, Provo, UT 84602, USA
1 shared publication - Bradley Charles Bundy
Department of Chemical and Biological Engineering, Brigham Young University, Provo, UT 84602, USA
1 shared publication - Dennis Della Corte
Department of Physics and Astronomy, Brigham Young University, Provo, UT 84602, USA
1 shared publication - Kristina M. McCammon
Department of Physics and Astronomy, Brigham Young University, Provo, UT 84602, USA
1 shared publication - Tyler P. Green
Department of Chemical Engineering, Brigham Young University, Provo, UT 84602, USA
1 shared publication - William P. Heaps
Department of Physics and Astronomy, Brigham Young University, Provo, UT 84602, USA
1 shared publication
Latest Publications
- Top Cited PapersOpen Access
- 13 January 2026
- Published by MDPI AG in Biophysica
- Vol. 6 (1) , 4
Molecular Survival Strategies Against Kidney Filtration: Implications for Therapeutic Protein Engineering
The glomerular filtration barrier poses a significant challenge for circulating proteins, with molecules below ~60–70 kDa facing rapid renal clearance. Endogenous proteins have evolved sophisticated evasion mechanisms including oligomerization, carrier binding, electrostatic repulsion, and FcRn-mediated recycling. Understanding these natural strategies provides blueprints for engineering therapeutic proteins with improved pharmacokinetics. This review examines how endogenous proteins resist filtration, evaluates their application in protein engineering, and discusses clinical translation including established technologies (PEGylation, Fc-fusion) and emerging strategies (albumin-binding domains, glycoengineering). We address critical challenges of balancing half-life extension with tissue penetration, biological activity, and immunogenicity—essential considerations for the rational design of next-generation therapeutics with optimized dosing and enhanced efficacy.
- 13 January 2026
- Published by MDPI AG in Biophysica
- Vol. 6 (1) , 4
Top Cited PapersOpen AccessMolecular Survival Strategies Against Kidney Filtration: Implications for Therapeutic Protein Engineering
The glomerular filtration barrier poses a significant challenge for circulating proteins, with molecules below ~60–70 kDa facing rapid renal clearance. Endogenous proteins have evolved sophisticated evasion mechanisms including oligomerization, carrier binding, electrostatic repulsion, and FcRn-mediated recycling. Understanding these natural strategies provides blueprints for engineering therapeutic proteins with improved pharmacokinetics. This review examines how endogenous proteins resist filtration, evaluates their application in protein engineering, and discusses clinical translation including established technologies (PEGylation, Fc-fusion) and emerging strategies (albumin-binding domains, glycoengineering). We address critical challenges of balancing half-life extension with tissue penetration, biological activity, and immunogenicity—essential considerations for the rational design of next-generation therapeutics with optimized dosing and enhanced efficacy.